Carisma therapeutics to participate in the 7th annual evercore isi healthconx conference

Philadelphia , nov. 27, 2024 /prnewswire/ -- carisma therapeutics inc. (nasdaq: carm) ("carisma" or the "company"), a clinical-stage biopharmaceutical company focused on discovering and developing innovative immunotherapies, today announced that steven kelly, president and chief executive officer, will participate in a fireside chat at the 7th annual evercore isi healthconx conference on thursday, december 5 th at 9:35 am et. an audio webcast of the event will be available on the company's investor events section of the investor relations webpage and will be archived for a limited time following the event.
EVR Ratings Summary
EVR Quant Ranking